ATE158506T1 - Okulare hypotensive 2-dekarboxyl-2-aminoalkyl- prostaglandine - Google Patents
Okulare hypotensive 2-dekarboxyl-2-aminoalkyl- prostaglandineInfo
- Publication number
- ATE158506T1 ATE158506T1 AT92900219T AT92900219T ATE158506T1 AT E158506 T1 ATE158506 T1 AT E158506T1 AT 92900219 T AT92900219 T AT 92900219T AT 92900219 T AT92900219 T AT 92900219T AT E158506 T1 ATE158506 T1 AT E158506T1
- Authority
- AT
- Austria
- Prior art keywords
- decarboxyl
- aminoalkyl
- prostaglandins
- occular
- hypotensive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Geophysics And Detection Of Objects (AREA)
- Feedback Control In General (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/611,029 US5270049A (en) | 1990-11-09 | 1990-11-09 | 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE158506T1 true ATE158506T1 (de) | 1997-10-15 |
Family
ID=24447325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92900219T ATE158506T1 (de) | 1990-11-09 | 1991-10-30 | Okulare hypotensive 2-dekarboxyl-2-aminoalkyl- prostaglandine |
Country Status (15)
Country | Link |
---|---|
US (1) | US5270049A (de) |
EP (1) | EP0556296B1 (de) |
JP (1) | JP3488456B2 (de) |
AT (1) | ATE158506T1 (de) |
AU (1) | AU656752B2 (de) |
BR (1) | BR9107071A (de) |
CA (1) | CA2095430A1 (de) |
DE (1) | DE69127755T2 (de) |
ES (1) | ES2107522T3 (de) |
HU (1) | HUT70500A (de) |
IE (1) | IE913906A1 (de) |
IL (1) | IL99975A (de) |
NZ (1) | NZ240502A (de) |
WO (1) | WO1992008465A2 (de) |
ZA (1) | ZA918869B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5288754A (en) * | 1992-02-04 | 1994-02-22 | Allergan, Inc. | Polar C-1 esters of prostaglandins |
US5972991A (en) | 1992-09-21 | 1999-10-26 | Allergan | Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
US5688819A (en) * | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
US5834498A (en) * | 1992-09-21 | 1998-11-10 | Allergan | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
US5328933A (en) * | 1992-10-28 | 1994-07-12 | Allergan, Inc. | Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues |
US6124353A (en) * | 1992-11-12 | 2000-09-26 | Allergan Sales, Inc. | Method of treating ocular hypertension with 8-epi prostaglandins |
US5545665A (en) * | 1993-12-28 | 1996-08-13 | Allergan | Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
US5698733A (en) * | 1994-09-30 | 1997-12-16 | Alcon Laboratories, Inc. | Use of 9-deoxy prostaglandin derivatives to treat glaucoma |
US6169111B1 (en) | 1995-06-07 | 2001-01-02 | Alcon Laboratories, Inc. | Conformationally rigid aryl prostaglandins for use in glaucoma therapy |
US6066671A (en) | 1997-12-19 | 2000-05-23 | Alcon Laboratories, Inc. | Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides |
US6646001B2 (en) | 1997-12-19 | 2003-11-11 | Alcon Manufacturing, Ltd. | Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension |
US6096783A (en) * | 1998-12-15 | 2000-08-01 | Alcon Laboratories, Inc. | Cyclobutane prostaglandin analogues as ocular hypotensive agents |
US6160013A (en) * | 1998-12-17 | 2000-12-12 | Alcon Laboratories, Inc. | 14-aza prostaglandins for the treatment of glaucoma and ocular hypertension |
US6211226B1 (en) | 1998-12-17 | 2001-04-03 | Alcon Laboratories, Inc. | 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension |
US20090148527A1 (en) * | 2007-12-07 | 2009-06-11 | Robinson Michael R | Intraocular formulation |
WO2010102078A1 (en) | 2009-03-04 | 2010-09-10 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
US7851504B2 (en) | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4085139A (en) * | 1975-12-29 | 1978-04-18 | The Upjohn Company | 2-Decarboxy-2-amino-methyl-PGE and PGD analogs |
US4599353A (en) * | 1982-05-03 | 1986-07-08 | The Trustees Of Columbia University In The City Of New York | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma |
DE3785602T2 (de) * | 1986-03-13 | 1993-09-02 | Univ Columbia | Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom. |
US4883819A (en) * | 1986-07-31 | 1989-11-28 | The Trustees Of Columbia University In The City Of New York | Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma |
US4824857A (en) * | 1986-05-16 | 1989-04-25 | Yasumasa Goh | Use of prostaglandin D2 -active substances |
US4952581A (en) * | 1987-04-03 | 1990-08-28 | The Trustees Of Columbia University In The City Of New York | Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure |
ES2052735T3 (es) * | 1987-09-18 | 1994-07-16 | R Tech Ueno Ltd | Un metodo para producir un agente hipotensor ocular. |
US4927846A (en) * | 1988-11-23 | 1990-05-22 | Allergan, Inc. | Intraocular pressure reducing 1,11-lactone prostaglandins |
US4994274A (en) * | 1989-07-27 | 1991-02-19 | Allergan, Inc. | Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using |
US5011856A (en) * | 1990-03-12 | 1991-04-30 | Allergan, Inc. | Use of prostaglandin F3 α as an ocular hypotensive agent |
US5238961A (en) * | 1990-06-14 | 1993-08-24 | Allergan, Inc. | Pgf 1-alcohols and their use as ocular hypotensives |
-
1990
- 1990-11-09 US US07/611,029 patent/US5270049A/en not_active Expired - Lifetime
-
1991
- 1991-10-30 AT AT92900219T patent/ATE158506T1/de not_active IP Right Cessation
- 1991-10-30 CA CA002095430A patent/CA2095430A1/en not_active Abandoned
- 1991-10-30 HU HU9301327A patent/HUT70500A/hu active IP Right Revival
- 1991-10-30 DE DE69127755T patent/DE69127755T2/de not_active Expired - Fee Related
- 1991-10-30 EP EP92900219A patent/EP0556296B1/de not_active Expired - Lifetime
- 1991-10-30 JP JP50084392A patent/JP3488456B2/ja not_active Expired - Fee Related
- 1991-10-30 BR BR919107071A patent/BR9107071A/pt not_active Application Discontinuation
- 1991-10-30 AU AU90414/91A patent/AU656752B2/en not_active Ceased
- 1991-10-30 ES ES92900219T patent/ES2107522T3/es not_active Expired - Lifetime
- 1991-10-30 WO PCT/US1991/007982 patent/WO1992008465A2/en active IP Right Grant
- 1991-11-06 IL IL9997591A patent/IL99975A/en active IP Right Grant
- 1991-11-07 NZ NZ240502A patent/NZ240502A/en unknown
- 1991-11-08 ZA ZA918869A patent/ZA918869B/xx unknown
- 1991-11-08 IE IE390691A patent/IE913906A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU656752B2 (en) | 1995-02-16 |
DE69127755T2 (de) | 1998-04-30 |
IL99975A (en) | 1996-05-14 |
BR9107071A (pt) | 1993-09-21 |
ES2107522T3 (es) | 1997-12-01 |
WO1992008465A3 (en) | 1992-10-15 |
HU9301327D0 (en) | 1993-09-28 |
EP0556296A1 (de) | 1993-08-25 |
AU9041491A (en) | 1992-06-11 |
JP3488456B2 (ja) | 2004-01-19 |
US5270049A (en) | 1993-12-14 |
ZA918869B (en) | 1992-07-29 |
WO1992008465A2 (en) | 1992-05-29 |
DE69127755D1 (de) | 1997-10-30 |
HUT70500A (en) | 1995-10-30 |
IE913906A1 (en) | 1992-05-20 |
CA2095430A1 (en) | 1992-05-10 |
EP0556296B1 (de) | 1997-09-24 |
IL99975A0 (en) | 1992-08-18 |
JPH06501482A (ja) | 1994-02-17 |
NZ240502A (en) | 1995-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE158506T1 (de) | Okulare hypotensive 2-dekarboxyl-2-aminoalkyl- prostaglandine | |
ES2138691T3 (es) | Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina. | |
NO912630L (no) | Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler | |
ES2134226T3 (es) | Derivados de s-triazina como fotoestabilizadores. | |
ES2071227T3 (es) | Composicion para gotas para los ojos. | |
ES2106700T3 (es) | Procedimiento para la preparacion de derivados de la 4a,5,9,10,11,12-hexahidro-6h-benzofuro(3a,3,2-ef)(2)benzacepinas. | |
ES2174298T3 (es) | Derivados de aminotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
FI98455B (fi) | Menetelmä terapeuttisesti aktiivisten indolijohdannaisten valmistamiseksi | |
ES2079872T3 (es) | Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina. | |
FI892222A0 (fi) | Peptidalkoholer med antikoagulantverkan. | |
ATE164763T1 (de) | Okulare hypotensive homo-prostaglandinderivate | |
ES2060944T3 (es) | Derivados de 2,5,6,7-tetranor-4,8-inter-m-fenileno de pgi2 (prostaglandina i2). | |
ES2072936T3 (es) | Derivados de pradimicin-amida. | |
WO1992010473A3 (en) | 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives | |
GR1001309B (el) | Μεθοδος παρασκευης παραγωγου ενωσεως της διχλωροανιλινης. | |
NO921317D0 (no) | Antimetastatisk virkende midler | |
ES512920A0 (es) | "procedimiento de preparacion de derivados de etanolamina". | |
BE860603A (fr) | Derives de l'oxadiazole-1,2,4 utilisables comme azureurs optiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |